Classification of Periodontal Pockets

Periodontal pockets are an important aspect of periodontal disease, reflecting the health of the supporting structures of the teeth. Understanding the classification of these pockets is essential for diagnosis, treatment planning, and management of periodontal conditions.

Classification of Pockets

1. Gingival Pocket:

   • Also Known As: Pseudo-pocket.
   • Formation:
     • Formed by gingival enlargement without destruction of the underlying periodontal tissues.
     • The sulcus is deepened due to the increased bulk of the gingiva.
   • Characteristics:
     • There is no destruction of the supporting periodontal tissues.
     • Typically associated with conditions such as gingival hyperplasia or inflammation.

2. Periodontal Pocket:

   • Definition: A pocket that results in the destruction of the supporting periodontal tissues, leading to the loosening and potential exfoliation of teeth.
   • Classification Based on Location:
     • Suprabony Pocket:
       • The base of the pocket is coronal to the alveolar bone.
       • The pattern of bone destruction is horizontal.
       • The transseptal fibers are arranged horizontally in the space between the base of the pocket and the alveolar bone.
     • Infrabony Pocket:
       • The base of the pocket is apical to the alveolar bone, meaning the pocket wall lies between the bone and the tooth.
       • The pattern of bone destruction is vertical.
       • The transseptal fibers are oblique rather than horizontal.

Classification of Periodontal Pockets

1. Suprabony Pocket (Supracrestal or Supraalveolar):

   • Location: Base of the pocket is coronal to the alveolar bone.
   • Bone Destruction: Horizontal pattern of bone loss.
   • Transseptal Fibers: Arranged horizontally.

2. Infrabony Pocket (Intrabony, Subcrestal, or Intraalveolar):

   • Location: Base of the pocket is apical to the alveolar bone.
   • Bone Destruction: Vertical pattern of bone loss.
   • Transseptal Fibers: Arranged obliquely.

Classification of Pockets According to Involved Tooth Surfaces

1. Simple Pocket:

   • Definition: Involves only one tooth surface.
   • Example: A pocket that is present only on the buccal surface of a tooth.

2. Compound Pocket:

   • Definition: A pocket present on two or more surfaces of a tooth.
   • Example: A pocket that involves both the buccal and lingual surfaces.

3. Spiral Pocket:

   • Definition: Originates on one tooth surface and twists around the tooth to involve one or more additional surfaces.
   • Example: A pocket that starts on the mesial surface and wraps around to the distal surface.

Treatment Phases

1. Phase 1: Non – surgical
2. Phase 2: Surgical
3. Phase 3: Restorative
4. Phase 4: Maintenance Must progress through Phase 1 → 4 before Phase 2 or 3

Merin's Classification

• Class A: 6 months – 1 year recall
• Class B: 3 – 4 months recall
• Class C: 1 – 3 months recall

COPD

• Reid's index: Used in chronic bronchitis
• Emphysema features: ↓DLCO, weight loss, pneumothorax risk
• Chronic bronchitis: Polycythemia
• GOLD criteria: COPD severity assessment
• BODE index: Lung transplant evaluation

Sleep Apnea

Definition: Breathing pause ≥10 seconds during sleep

ASTHMA

Diagnosis & Pathophysiology

• Best diagnostic test: Demonstration of reversible obstruction
• Small airways involved
• Idiosyncratic asthma: Normal IgE levels
• Aspirin-sensitive asthma: Associated with nasal polyps

Key Points

• Charcot-Leyden crystals: Eosinophil granules
• Nebulizer droplet size: <2.5 μm
• Most severe attack indicator: Bradycardia
• Montelukast: NOT useful in acute bronchial asthma

Platelet-Derived Growth Factor (PDGF)

Platelet-Derived Growth Factor (PDGF) is a crucial glycoprotein involved in various biological processes, particularly in wound healing and tissue repair. Understanding its role and mechanisms can provide insights into its applications in regenerative medicine and periodontal therapy.

Overview of PDGF

1. Definition:

   • PDGF is a glycoprotein that plays a significant role in cell growth, proliferation, and differentiation.

2. Source:

   • PDGF is carried in the alpha granules of platelets and is released during the process of blood clotting.

3. Discovery:

   • It was one of the first growth factors to be described in scientific literature.
   • Originally isolated from platelets, PDGF was found to exhibit mitogenic activity specifically in smooth muscle cells.

Functions of PDGF

1. Mitogenic Activity:

   • PDGF stimulates the proliferation of various cell types, including:
     • Smooth muscle cells
     • Fibroblasts
     • Endothelial cells
   • This mitogenic activity is essential for tissue repair and regeneration.

2. Role in Wound Healing:

   • PDGF is released at the site of injury and plays a critical role in:
     • Promoting cell migration to the wound site.
     • Stimulating the formation of new blood vessels (angiogenesis).
     • Enhancing the synthesis of extracellular matrix components, which are vital for tissue structure and integrity.

3. Involvement in Periodontal Healing:

   • In periodontal therapy, PDGF can be utilized to enhance healing in periodontal defects and promote regeneration of periodontal tissues.
   • It has been studied for its potential in guided tissue regeneration (GTR) and in the treatment of periodontal disease.

Clinical Applications

1. Regenerative Medicine:

   • PDGF is being explored in various regenerative medicine applications, including:
     • Bone regeneration
     • Soft tissue healing
     • Treatment of chronic wounds

2. Periodontal Therapy:

   • PDGF has been incorporated into certain periodontal treatment modalities to enhance healing and regeneration of periodontal tissues.
   • It can be used in conjunction with graft materials to improve outcomes in periodontal surgery.

Aggressive periodontitis (AP) is a multifactorial, severe, and rapidly progressive form of periodontitis that primarily affects younger patients. It is characterized by a unique set of clinical and microbiological features that distinguish it from other forms of periodontal disease.

Key Characteristics

• Rapid Progression: AP is marked by a swift deterioration of periodontal tissues.
• Age Group: Primarily affects adolescents and young adults, but can occur at any age.
• Multifactorial Etiology: Involves a combination of microbiological, immunological, genetic, and environmental factors.

Other Findings

• Presence of Aggregatibacter actinomycetemcomitans (A.a.) in diseased sites.
• Abnormal host responses, including impaired phagocytosis and chemotaxis.
• Hyperresponsive macrophages leading to exaggerated inflammatory responses.
• The disease may exhibit self-arresting tendencies in some cases.

Classification

Aggressive periodontitis can be classified into two main types:

1. Localized Aggressive Periodontitis (LAP): Typically affects the permanent molars and incisors, often with localized attachment loss.
2. Generalized Aggressive Periodontitis (GAP): Involves more widespread periodontal tissue destruction.

Risk Factors

Microbiological Factors

• Aggregatibacter actinomycetemcomitans: A primary pathogen associated with LAP, producing a potent leukotoxin that kills neutrophils.
• Different strains of A.a. produce varying levels of leukotoxin, with highly toxic strains more prevalent in affected individuals.

Immunological Factors

• Human Leukocyte Antigens (HLAs): HLA-A9 and B-15 are candidate markers for aggressive periodontitis.
• Defective neutrophil function leads to impaired chemotaxis and phagocytosis.
• Hyper-responsive macrophage phenotype, characterized by elevated levels of PGE2 and IL-1β, may contribute to connective tissue breakdown and bone loss.

Genetic Factors

• Familial clustering of neutrophil abnormalities suggests a genetic predisposition.
• Genetic control of antibody responses to A.a., with variations in the ability to produce protective IgG2 antibodies.

Environmental Factors

• Smoking is a significant risk factor, with smokers experiencing more severe periodontal destruction compared to non-smokers.

Treatment Approaches

General Considerations

• Treatment strategies depend on the type and extent of periodontal destruction.
• GAP typically has a poorer prognosis compared to LAP, as it is less likely to enter spontaneous remission.

Conventional Periodontal Therapy

• Patient Education: Informing patients about the disease and its implications.
• Oral Hygiene Instructions: Reinforcing proper oral hygiene practices.
• Scaling and Root Planing: Removal of plaque and calculus to control local factors.

Surgical Resection Therapy

• Aimed at reducing or eliminating pocket depth.
• Contraindicated in cases of severe horizontal bone loss due to the risk of increased tooth mobility.

Regenerative Therapy

• Potential for regeneration is promising in AP cases.
• Techniques include open flap surgical debridement, root surface conditioning with tetracycline, and the use of allogenic bone grafts.
• Recent advances involve the use of enamel matrix proteins to promote cementum regeneration and new attachment.

Antimicrobial Therapy

• Often required as adjunctive treatment to eliminate A.a. from periodontal tissues.
• Tetracycline: Administered in various regimens to concentrate in periodontal tissues and inhibit A.a. growth.
• Combination Therapy: Metronidazole combined with amoxicillin has shown efficacy alongside periodontal therapy.
• Doxycycline: Used at a dose of 100 mg/day.
• Chlorhexidine (CHX): Irrigation and home rinsing to control bacterial load.

Host Modulation

• Involves the use of sub-antimicrobial dose doxycycline (SDD) to prevent periodontal attachment loss by modulating the activity of matrix metalloproteinases (MMPs), particularly collagenase and gelatinase.

Periodontal Diseases Associated with Neutrophil Disorders

1. Acute Necrotizing Ulcerative Gingivitis (ANUG)

   • Description: A severe form of gingivitis characterized by necrosis of the interdental papillae, pain, and foul odor.
   • Association: Neutrophil dysfunction can exacerbate the severity of ANUG, leading to rapid tissue destruction.

2. Localized Juvenile Periodontitis

   • Description: A form of periodontitis that typically affects adolescents and is characterized by localized bone loss around the permanent teeth.
   • Association: Impaired neutrophil function contributes to the pathogenesis of this condition.

3. Prepubertal Periodontitis

   • Description: A rare form of periodontitis that occurs in children before puberty, leading to rapid attachment loss and bone destruction.
   • Association: Neutrophil disorders can play a significant role in the development and progression of this disease.

4. Rapidly Progressive Periodontitis

   • Description: A form of periodontitis characterized by rapid attachment loss and bone destruction, often occurring in young adults.
   • Association: Neutrophil dysfunction may contribute to the aggressive nature of this disease.

5. Refractory Periodontitis

   • Description: A form of periodontitis that does not respond to conventional treatment and continues to progress despite therapy.
   • Association: Neutrophil disorders may be implicated in the persistent nature of this condition.